Patent details
EP2395983 Title: PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF
Basic Information
- Publication number:
- EP2395983
- PCT Application Number:
- EP2010051736
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP107032880
- PCT Publication Number:
- WO2010092125
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF
- French Title of Invention:
- COMPOSITION PHARMACEUTIQUE CONTENANT UN INHIBITEUR SGLT2 EN COMBINAISON AVEC UN INHIBITEUR DPP-IV ET OPTIOENELLEMENT UN AUTRE AGENT ANTIDIABETIQUE
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT EINEM SGLT2-INHIBITOR, EINEM DPP-IV-INHIBITOR UND OPTIONAL EINEM WEITEREN ANTIDIABETISCHEN MITTEL UND IHRE VERWENDUNG
- SPC Number:
Dates
- Filing date:
- 11/02/2010
- Grant date:
- 08/04/2020
- EP Publication Date:
- 21/12/2011
- PCT Publication Date:
- 19/08/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/04/2020
- EP B1 Publication Date:
- 08/04/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 11/02/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/04/2020
- Name:
- Boehringer Ingelheim International GmbH
- Address:
- Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)
Inventor
1
- Name:
- EICKELMANN, Peter
- Address:
- Germany (DE)
2
- Name:
- MARK,Michael
- Address:
- Germany (DE)
3
- Name:
- BROEDL, Uli
- Address:
- Germany (DE)
4
- Name:
- THOMAS, Leo
- Address:
- Germany (DE)
5
- Name:
- GREMPLER, Rolf
- Address:
- Germany (DE)
6
- Name:
- SEMAN, Leo John
- Address:
- United States (US)
Priority
- Priority Number:
- 152302 P
- Priority Date:
- 13/02/2009
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/155; A61K 31/341; A61K 31/522; A61K 31/7048; A61P 3/10;
Publication
European Patent Bulletin
1
- Issue number:
- 202015
- Publication date:
- 08/04/2020
- Description:
- Grant (B1)
2
- Issue number:
- 202108
- Publication date:
- 24/02/2021
- Description:
- Opposition procedure started
3
- Issue number:
- 202104
- Publication date:
- 27/01/2021
- Description:
- Opposition procedure started
Annual Fees
- Annual Fee Due Date:
- 02/03/2026
- Annual Fee Number:
- 17
- Annual Fee Amount:
- 246 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 18/02/2025
- Last Annual Fee Paid Number:
- 16
- Last Annual Fee Paid Amount:
- 230 Euro
- Payer:
- DENNEMEYER & CO
| Filing date | Document type | Number of pages |
|---|